Icahn gets Legault onto Forest's board
This article was originally published in Scrip
Executive Summary
Activist investor Carl Icahn has succeeded in securing board representation at Forest Laboratories. One of his four candidates, Pierre Legault, former CFO at OSI Pharmaceuticals, beat longstanding board member and chair of Forest's compensation committee Dan Goldwasser to secure one of 10 director positions, giving Mr Icahn increased leverage in his bid to push through change at the company.